Skip to main content
Livermore
Livermore
ZHEN

Ernexa Therapeutics Inc.

ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000748592

No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.

Other share classesERNAW

Holders of 5% or more of ERNA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ernexa Therapeutics Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ERNA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Cherington Charles13D/A34.70%10.8M shares−3.20 ppfrom 37.90%May 13, 20219 filingsFeb 17, 2026SEC
Freebird Partners LP13G/A9.90%6.21M shares−0.09 ppfrom 9.99%Dec 2, 20225 filingsMay 14, 2025SEC
Freebird Partners LP13G/A9.90%786.0K shares–Dec 19, 20251 filingDec 19, 2025SEC
Freebird Partners LP13G/A9.90%120.4K shares–May 15, 20261 filingMay 15, 2026SEC
Konar Shameek13G/A9.70%118.3K shares+4.20 ppfrom 5.50%May 15, 20252 filingsMay 13, 2026SEC
Konar Shameek13G/A7.12%558.5K shares–Dec 16, 20251 filingDec 16, 2025SEC
Bleichroeder LP13G6.86%80.0K sharesNewMay 14, 20261 filingMay 14, 2026SEC
Halpern John D13G/A5.60%66.8K shares−4.00 ppfrom 9.60%May 24, 20217 filingsMay 15, 2026SEC
Iaf, LLC13G/A5.20%3.26M shares−0.02 ppfrom 5.22%Dec 20, 20233 filingsMay 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

53 Schedule 13D and 13G filings on Ernexa Therapeutics Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ERNA
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 20, 20264:50 PM ETClear Street LLC13G/A0.00%0 shares−12.80 ppfrom 12.80%Below 5%May 5, 2026SEC
May 15, 20268:54 PM ETFreebird Partners LPand 2 others13G/A9.90%120.4K shares–Feb 10, 2026SEC
May 15, 20268:50 PM ETHalpern John Dand 1 other13G/A5.60%66.8K shares−4.00 ppfrom 9.60%Feb 10, 2026SEC
May 14, 20265:45 PM ETBleichroeder LPand 2 others13G6.86%80.0K sharesNewMar 31, 2026SEC
May 14, 202612:31 PM ETClear Street LLC13G12.80%149.5K sharesNewMay 5, 2026SEC
May 13, 20269:49 PM ETKonar Shameekand 2 others13G/A9.70%118.3K shares+4.20 ppfrom 5.50%Feb 10, 2026SEC
Feb 17, 20269:26 PM ETCherington Charles13D/A34.70%10.8M shares−3.20 ppfrom 37.90%Feb 10, 2026SEC
Dec 19, 20253:50 PM ETFreebird Partners LPand 2 others13G/A9.90%786.0K shares–Dec 19, 2025SEC
Dec 16, 20255:42 PM ETKonar Shameekand 2 others13G/A7.12%558.5K shares–Jun 30, 2025SEC
Aug 18, 20254:05 PM ETIaf, LLC13G/A4.10%315.8K shares–Below 5%Jul 28, 2025SEC
Jun 11, 20258:39 PM ETCherington Charles13D/A37.90%41.7M shares+5.10 ppfrom 32.80%Jun 9, 2025SEC
May 15, 20259:13 PM ETHalpern John Dand 1 other13G/A9.60%5.97M shares−0.39 ppfrom 9.99%Mar 31, 2025SEC
May 15, 20254:42 PM ETKonar Shameekand 2 others13G5.50%3.44M sharesNewMar 31, 2025SEC
May 14, 20258:39 PM ETIaf, LLC13G/A5.20%3.26M shares−0.02 ppfrom 5.22%Mar 31, 2025SEC
May 14, 20252:14 PM ETFreebird Partners LPand 2 others13G/A9.90%6.21M shares−0.09 ppfrom 9.99%Mar 31, 2025SEC
Apr 4, 202510:55 AM ETCherington Charles13D/A32.80%20.4M shares+0.42 ppfrom 32.38%Apr 2, 2025SEC
Mar 5, 20255:55 PM ETCherington Charles13D/A32.38%16.6M shares–Oct 29, 2024SEC
Feb 14, 20259:30 PM ETSinger Nicholas Jasonand 1 other13G/A4.92%2.57M shares–Below 5%Dec 31, 2024SEC
Feb 14, 20258:36 PM ETHalpern John Dand 1 other13G/A9.99%5.14M shares–Oct 29, 2024SEC
Feb 12, 20255:54 PM ETIaf, LLC13G/A5.22%2.68M shares–Oct 29, 2024SEC
Jan 28, 20255:31 PM ETFreebird Partners LPand 2 others13G/A9.99%5.14M shares–Oct 29, 2024SEC
Jan 31, 2024Halpern John D13G/AOld format–––SEC
Jan 19, 2024Singer Nicholas Jason13G/AOld format–––SEC
Dec 22, 2023Cherington Charles13D/AOld format–––SEC
Dec 20, 2023Iaf, LLC13GOld format–New–SEC
Sep 8, 2023Singer Nicholas Jason13G/AOld format–––SEC
Sep 7, 2023Cherington Charles13D/AOld format–––SEC
Aug 28, 2023Purchase Capital LLC13GOld format–New–SEC
Jul 26, 2023Singer Nicholas Jason13D/AOld format–––SEC
Jul 21, 2023Freebird Partners LP13G/AOld format–––SEC
Apr 4, 2023Freebird Partners LP13G/AOld format–––SEC
Mar 6, 2023Denny George P III13G/AOld format–––SEC
Jan 31, 2023Halpern John D13G/AOld format–––SEC
Dec 20, 2022Singer Nicholas Jason13DOld format–––SEC
Dec 14, 2022Cherington Charles13D/AOld format–––SEC
Dec 5, 2022Halpern John D13G/AOld format–––SEC
Dec 2, 2022Freebird Partners LP13GOld format–New–SEC
Mar 16, 2022Cherington Charles13D/AOld format–––SEC
Feb 16, 2022Singer Nicholas Jason13G/AOld format–––SEC
Aug 27, 2021Factor Bioscience Inc.13GOld format–New–SEC
May 26, 2021Custard & Pitts Investment Co. LP13G/AOld format–––SEC
May 24, 2021Halpern John D13GOld format–New–SEC
May 18, 2021Custard & Pitts Investment Co. LP13GOld format–New–SEC
May 13, 2021Denny George P III13GOld format–New–SEC
May 13, 2021Cherington Charles13DOld format–New–SEC
May 4, 2021Gentile Guy13G/AOld format–––SEC
Apr 30, 2021Singer Nicholas Jason13GOld format–New–SEC
Mar 17, 20214:30 PM ETAult Global Holdings, Inc.13D/AOld format–––SEC
Mar 16, 20214:30 PM ETAult Global Holdings, Inc.13D/AOld format–––SEC
Feb 22, 20214:30 PM ETAult Global Holdings, Inc.13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Ernexa Therapeutics Inc. shares.

No Form 144 notices for Ernexa Therapeutics Inc. are on file.